Literature DB >> 8302604

Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo.

B J Pulverer1, C Fisher, K Vousden, T Littlewood, G Evan, J R Woodgett.   

Abstract

c-Myc is a nuclear phosphoprotein which binds DNA as a heterodimer with Max. We have identified two in vivo phosphorylation sites, Thr58 and Ser62, within a domain highly conserved among all Myc family members. Thr58 is mutated in several viral forms of the protein and constitutes a mutational hot-spot in Burkitt's lymphoma. Members of the GSK-3 and MAP kinase families, but not CKII, specifically phosphorylated these sites in vitro. The effect of these phosphorylation sites on Myc function was assessed by cotransformation of primary rat embryo fibroblasts with Ras. Mutagenesis of Thr58 to alanine potentiated focus formation, whereas substitution of Ser62 severely inhibited transformation. Mutation of both residues restored wild-type activity. These data suggest acute, post-translational modulation of Myc via phosphorylation of a conserved region previously implicated in transactivation, transformation and autorepression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8302604

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  85 in total

Review 1.  The Max network gone mad.

Authors:  T A Baudino; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.

Authors:  M A Gregory; S R Hann
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals.

Authors:  D W Chang; G F Claassen; S R Hann; M D Cole
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

Authors:  R Sears; F Nuckolls; E Haura; Y Taya; K Tamai; J R Nevins
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

Review 5.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

6.  Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes.

Authors:  Izidore S Lossos; Ash A Alizadeh; Maximilian Diehn; Roger Warnke; Yvonne Thorstenson; Peter J Oefner; Patrick O Brown; David Botstein; Ronald Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

7.  Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1.

Authors:  Brian M Iritani; Jeffrey Delrow; Carla Grandori; Ivan Gomez; Meredith Klacking; Leni Sue Carlos; Robert N Eisenman
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

Review 8.  Integrin signalling and the cellular response to ionizing radiation.

Authors:  Nils Cordes; Viktor Meineke
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

9.  Autoregulatory suppression of c-Myc by miR-185-3p.

Authors:  Jun-Ming Liao; Hua Lu
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

10.  Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis.

Authors:  B Lutterbach; S R Hann
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.